ES2172681T3 - Piramidinas y triazinas sustituidas con amino. - Google Patents

Piramidinas y triazinas sustituidas con amino.

Info

Publication number
ES2172681T3
ES2172681T3 ES96934690T ES96934690T ES2172681T3 ES 2172681 T3 ES2172681 T3 ES 2172681T3 ES 96934690 T ES96934690 T ES 96934690T ES 96934690 T ES96934690 T ES 96934690T ES 2172681 T3 ES2172681 T3 ES 2172681T3
Authority
ES
Spain
Prior art keywords
rent
hydrogen
amino
replaced
mono
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96934690T
Other languages
English (en)
Inventor
Thomas R Webb
Terence J Moran
James R Mccarthy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Neurocrine Biosciences Inc
Original Assignee
Janssen Pharmaceutica NV
Neurocrine Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NV, Neurocrine Biosciences Inc filed Critical Janssen Pharmaceutica NV
Application granted granted Critical
Publication of ES2172681T3 publication Critical patent/ES2172681T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C07D239/49—Two nitrogen atoms with an aralkyl radical, or substituted aralkyl radical, attached in position 5, e.g. trimethoprim
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/14—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)

Abstract

PIRIMIDINAS Y TRIAZINAS DE FORMULA (I), DONDE R ES ALQUILO C 1-6 , AMINO, MONO- O DIALQUIL C 1-6 AMINO; R 1 ES HIDROGENO, ALQUILO C 1-6 , ALQUENILO C 3-6 , HIDROXIALQUILO C 1-6 O ALQUILOXI C 1-6 - ALQUILO C 16 ; R 2 ES ALQUILO C 1-6 , MONO- O DICICLOALQUIL C SU B,3-6 METILO, FENILMETILO, FENILMETILO SUSTITUIDO, ALQUILOXI C1-6 - ALQUILO C 1-6 , HIDROXIALQUILO C 1-6 , ALQ UIL C 1-6 OXICARBONILALQUILO C 1-6 , ALQUENILO C 3-6 ; O R 1 Y R 2 JUNTO CON EL NITROGENO AL QUE ESTAN UNIDOS PUEDEN FORMAR UN GRUPO PIRROLIDINILO, MORFOLINILO O PIPERIDINILO; X ES N O CR 3 ; R 3 ES HIDROGENO O ALQUILO C 1-6 ; R 4 ES FENILO O FENILO SUSTITUIDO; A ES - C(=O) -, (A), O - CR 7 R 8 - DONDE R 5 Y R 6 S ON CADA UNO INDEPENDIENTEMENTE HIDROGENO O ALQUILO C 1-4 ; R 7 ES HIDROGENO O OH; R 8 ES HIDROGENO O ALQUILO C SUB,1-6 ; QUE TIENEN PROPIEDADES ANTAGONISTICAS DE RECEPTORES CRF; COMPOSICIONES FARMACEUTICAS QUE CONTIENEN ESTOS COMPUESTOS COMO PRINCIPIOS ACTIVOS; METODOS PARA TRATAR DESORDENES RELACIONADOS CON LA HIPERSECRECION DE CRF TALES COMO DEPRESION, ANSIEDAD Y ABUSO DE SUSTANCIAS, MEDIANTE ADMINISTRACION DE UNA CANTIDAD EFECTIVA DE UN COMPUESTO DE FORMULA (I).
ES96934690T 1995-10-17 1996-10-15 Piramidinas y triazinas sustituidas con amino. Expired - Lifetime ES2172681T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US568795P 1995-10-17 1995-10-17

Publications (1)

Publication Number Publication Date
ES2172681T3 true ES2172681T3 (es) 2002-10-01

Family

ID=21717189

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96934690T Expired - Lifetime ES2172681T3 (es) 1995-10-17 1996-10-15 Piramidinas y triazinas sustituidas con amino.

Country Status (18)

Country Link
US (1) US6288060B1 (es)
EP (1) EP0863882B1 (es)
JP (1) JPH11513678A (es)
KR (1) KR19990045744A (es)
AR (1) AR004221A1 (es)
AT (1) ATE212987T1 (es)
AU (1) AU703096B2 (es)
CA (1) CA2229710A1 (es)
DE (1) DE69619125T2 (es)
DK (1) DK0863882T3 (es)
ES (1) ES2172681T3 (es)
MY (1) MY113945A (es)
NO (1) NO310771B1 (es)
NZ (1) NZ320227A (es)
PT (1) PT863882E (es)
TW (1) TW378206B (es)
WO (1) WO1997014684A1 (es)
ZA (1) ZA968732B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6124289A (en) * 1996-07-24 2000-09-26 Dupont Pharmaceuticals Co. Azolo triazines and pyrimidines
US6060478A (en) * 1996-07-24 2000-05-09 Dupont Pharmaceuticals Azolo triazines and pyrimidines
US6313124B1 (en) 1997-07-23 2001-11-06 Dupont Pharmaceuticals Company Tetrazine bicyclic compounds
US6191131B1 (en) 1997-07-23 2001-02-20 Dupont Pharmaceuticals Company Azolo triazines and pyrimidines
US7094782B1 (en) 1996-07-24 2006-08-22 Bristol-Myers Squibb Company Azolo triazines and pyrimidines
DE19837387A1 (de) * 1998-08-18 2000-02-24 Aventis Res & Tech Gmbh & Co 3'-Desoxypentopyranosyl-Nucleinsäure, ihre Herstellung und Verwendung
WO2000049001A2 (en) * 1999-02-16 2000-08-24 E.I. Du Pont De Nemours And Company Phenoxy-, phenylthio-, phenylamino-, benzyloxy-, benzylthio- or benzylaminopyrimidine insectidices and acaricides
US6432989B1 (en) 1999-08-27 2002-08-13 Pfizer Inc Use of CRF antagonists to treat circadian rhythm disorders
PL354784A1 (en) 1999-09-30 2004-02-23 Neurogen Corporation Certain alkylene diamine-substituted heterocycles
US6525067B1 (en) * 1999-11-23 2003-02-25 Pfizer Inc Substituted heterocyclic derivatives
AU2001234180A1 (en) * 2000-02-25 2001-09-03 Japan Tobacco Inc. Benzamide derivative and use thereof
CA2416248A1 (en) 2000-07-18 2002-01-24 Neurogen Corporation 5-substituted 2-aryl-4-pyrimidinones
CN100415725C (zh) 2000-09-19 2008-09-03 住友化学工业株式会社 嘧啶类化合物及其用途
JP2004509863A (ja) 2000-09-21 2004-04-02 ブリストル−マイヤーズ　スクイブ　カンパニー コルチコトロピン放出因子のインヒビターとしての置換アゾール誘導体
US20030055249A1 (en) * 2001-07-17 2003-03-20 Fick David B. Synthesis and methods of use of pyrimidine analogues and derivatives
US6872827B2 (en) 2002-04-26 2005-03-29 Chembridge Research Laboratories, Inc. Somatostatin analogue compounds
WO2005000404A2 (en) * 2003-05-29 2005-01-06 Synta Pharmaceuticals, Corp. Heterocyclic compounds for preventing and treating disorders associated with excessive bone loss
US20060024661A1 (en) * 2003-07-30 2006-02-02 The Regents Of The University Of California Modulation of CRF potentiation of NMDA receptor currents via CRF receptor 2

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2595697B1 (fr) 1986-03-13 1988-07-08 Rousselot Cie Derives de benzyl-pyrimidine, leur procede de preparation ainsi que les compositions en contenant
FR2692893B1 (fr) 1992-06-24 1994-09-02 Sanofi Elf Dérivés alkylamino ramifiés du thiazole, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.
WO1995010506A1 (en) * 1993-10-12 1995-04-20 The Du Pont Merck Pharmaceutical Company 1n-alkyl-n-arylpyrimidinamines and derivatives thereof
TW530047B (en) * 1994-06-08 2003-05-01 Pfizer Corticotropin releasing factor antagonists

Also Published As

Publication number Publication date
DE69619125T2 (de) 2002-09-26
NO310771B1 (no) 2001-08-27
KR19990045744A (ko) 1999-06-25
TW378206B (en) 2000-01-01
US6288060B1 (en) 2001-09-11
DK0863882T3 (da) 2002-05-06
JPH11513678A (ja) 1999-11-24
CA2229710A1 (en) 1997-04-24
PT863882E (pt) 2002-07-31
NZ320227A (en) 1998-11-25
ATE212987T1 (de) 2002-02-15
AU703096B2 (en) 1999-03-18
NO981623D0 (no) 1998-04-08
EP0863882B1 (en) 2002-02-06
DE69619125D1 (de) 2002-03-21
EP0863882A1 (en) 1998-09-16
WO1997014684A1 (en) 1997-04-24
ZA968732B (en) 1998-04-16
AR004221A1 (es) 1998-11-04
MY113945A (en) 2005-12-14
NO981623L (no) 1998-06-09
AU7292996A (en) 1997-05-07

Similar Documents

Publication Publication Date Title
ES2172681T3 (es) Piramidinas y triazinas sustituidas con amino.
ES2168237T1 (es) Pirazolopirimidinas que actuan como antagonistas del receptor del crf.
FR2714378B1 (fr) Dérivés de l'indol-2-one substitués en 3 par un groupe azoté, leur préparation, les compositions pharmaceutiques en contenant.
EA200200417A1 (ru) Фармацевтически активные производные сульфонамида
IL96486A0 (en) Tricyclic compounds,their preparation and pharmaceutical compositions containing them
NZ330118A (en) Thiophenopyrimidines, pharmaceutical compositions thereof and use in treating endocrine, psychiatric and neurologic conditions
ECSP941135A (es) Antagonistas triciclicos de vasopresina de benzacepina
FI934274A0 (fi) N-sulfonyl-2-oxi-indolderivat, deras framstaellning och dessa innehaollande farmaceutiska kompositioner
EA200400466A1 (ru) Производные пиперазина с антагонистической активностью к рецептору ccr1
UA84022C2 (ru) Производные (тио)карбамоилциклогексана как антагонисты d3/d2 рецептора
CA2272291A1 (en) Crf antagonistic quino- and quinazolines
DE60234092D1 (de) Agonisten und antagonisten von sphingosin-1-phosphatrezeptoren
ES2194452T3 (es) Composiciones antitranspirantes que contienen 1,2-hexanodiol.
EA200000614A1 (ru) 2,3-замещенные соединения индола в качестве ингибиторов сох-2
ATE70056T1 (de) Oxopyrimidin-derivate und sie enthaltende pharmazeutische zubereitungen.
IL136911A0 (en) Heterocyclic topoisomerase poisons
ATE142421T1 (de) Fungizide zusammensetzung
GR900100340A (en) New compositions
CO4340722A1 (es) Composicion herbicida que contiene como componentes activos ciertos derivados de 1,3-oxazin-4-ona de la formula (i) y .
BR9913757A (pt) Composto, e, agentes controladores de praga
DE69226931D1 (de) Guanidinothiazolederivate und ihre Anwendung als H2-Rezeptor-Antagonisten
ES2078651T3 (es) Compuesto de piridinsulfonamida sustituida o una sal del mismo, procedimiento para su preparacion y herbicida que lo contiene.
EA199900460A1 (ru) Производные бензолсульфоамида и лекарственные средства, содержащие упомянутые производные
ES2086857T3 (es) Derivados de 3-azabiciclo(3.1.0)hexano-2-ona y composiciones herbicidas que los contienen como ingredientes herbicidamente activos.
MX9302161A (es) Compuestos triciclicos antagonistas de la taquiqu inina, proceso para su preparcion y composiciones farmaceuticas que los contienen.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 863882

Country of ref document: ES